Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MetaSystems and mtm to develop imaging system

This article was originally published in Clinica

Executive Summary

Microscopic imaging specialist MetaSystems is to develop a new automated imaging system for cytology slides, in a co-development partnership with fellow German firm mtm laboratories. As part of the deal, the two Heidelberg-based firms will incorporate mtm’s CINtec cytology products into the new technology. According to mtm, the CINtec kit is a qualitative, immunocytochemical assay for the evaluation of the biomarker 16INK4A, an indicator of the cervical disease. The new system will use CINtec and MetaSystems’ Metafer slide scanning and imaging platform to achieve equal or better sensitivity and specificity, and greater efficiency, compared to manual observation of cytology slides. The agreement may also lead to a co-promotion deal if a product is successfully brought to market. Financial terms of the partnership were not disclosed.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT043041

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel